Resource Centre
Our aim is to provide easy access to the latest, most credible information about pharmacogenomics in the UK. From in-depth articles explaining the science behind PGx to training courses for healthcare professionals, our Resource Center is designed to educate, inform and empower individuals and practitioners alike.
THE PROBLEM WITH ANTIDEPRESSANTS
Antidepressants can be a crucial part of treating depression and anxiety, but they come with several challenges and potential issues.
WEBINAR: TRANSFORMING PATIENT OUTCOMES WITH PERSONALISED MEDICINE
Join us for an informative and inspiring webinar on Pharmacogenomics, led by Mantara Health’s Founder and Chairman, Dr Mark Hudson-Peacock.
Clopidogrel, Stroke Prevention & Pharmacogenomics
Studies show that 30% of individuals have genetic variants that prevent Clopidogrel, a commonly prescribed medication for stroke & heart attack prevention, from working.
NHS England: Clopidogrel & PGx
Some individuals have genetic variants in the CYP2C19 gene, which can have an impact on the efficacy of clopidogrel, a stroke-prevention drug.
NHS England: Introduction to Pharmacogenomics
NHS England has released a highly informative educational resource on pharmacogenomics, now available on Health Education England’s (HEE) website.
Genomics Education Programme: Pharmacogenomics and Stratified Healthcare
Health Education England provide training for healthcare practitioners in Pharmacogenomics and Stratified Healthcare.
